Physician profile
Anne Carr
NPI 1215142062
$800.87
in general payments reported to CMS, 2019-2025
17 companies · $44.10 in 2025
The $44.10 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.41 · 2020: $13.13 · 2021: $65.75 · 2022: $323 · 2023: $291 · 2024: $23.49 · 2025: $44.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $313.46 | 2022-2023 | Ova1 |
| Channel Medsystems, INC. | $82.81 | 2023 | |
| Abbvie INC. | $51.44 | 2022-2023 | Lo Loestrin Fe |
| Biohaven Pharmaceuticals, INC. | $49.69 | 2020-2021 | |
| Daiichi Sankyo INC. | $48.17 | 2019-2023 | Injectafer |
| Hologic Sales and Service, LLC | $42.75 | 2024-2025 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Organon LLC | $39.12 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.79 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $21.36 | 2023 | Myfembree |
| Biohaven Pharmaceutical Holding Company Ltd. | $19.46 | 2022 | |
| Mayne Pharma Commercial LLC | $17.10 | 2022 | |
| Abbott Laboratories | $15.67 | 2021 | |
| Therapeuticsmd, INC. | $14.82 | 2022 | |
| Pfizer INC. | $14.50 | 2025 | |
| Coopersurgical, INC. | $13.54 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $13.52 | 2021 | |
| Evofem Biosciences, INC. | $12.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.